1. Home
  2. RNA vs STNE Comparison

RNA vs STNE Comparison

Compare RNA & STNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • STNE
  • Stock Information
  • Founded
  • RNA 2012
  • STNE 2012
  • Country
  • RNA United States
  • STNE Cayman Islands
  • Employees
  • RNA N/A
  • STNE N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • STNE EDP Services
  • Sector
  • RNA Health Care
  • STNE Technology
  • Exchange
  • RNA Nasdaq
  • STNE Nasdaq
  • Market Cap
  • RNA 4.0B
  • STNE 5.0B
  • IPO Year
  • RNA 2020
  • STNE 2018
  • Fundamental
  • Price
  • RNA $70.58
  • STNE $17.89
  • Analyst Decision
  • RNA Buy
  • STNE Buy
  • Analyst Count
  • RNA 20
  • STNE 8
  • Target Price
  • RNA $69.26
  • STNE $17.44
  • AVG Volume (30 Days)
  • RNA 10.0M
  • STNE 4.9M
  • Earning Date
  • RNA 11-10-2025
  • STNE 11-06-2025
  • Dividend Yield
  • RNA N/A
  • STNE N/A
  • EPS Growth
  • RNA N/A
  • STNE N/A
  • EPS
  • RNA N/A
  • STNE N/A
  • Revenue
  • RNA $20,868,000.00
  • STNE $2,670,485,228.00
  • Revenue This Year
  • RNA N/A
  • STNE $17.20
  • Revenue Next Year
  • RNA $108.97
  • STNE $7.55
  • P/E Ratio
  • RNA N/A
  • STNE N/A
  • Revenue Growth
  • RNA 106.27
  • STNE 24.14
  • 52 Week Low
  • RNA $21.51
  • STNE $7.72
  • 52 Week High
  • RNA $70.76
  • STNE $19.95
  • Technical
  • Relative Strength Index (RSI)
  • RNA 80.20
  • STNE 46.81
  • Support Level
  • RNA $69.67
  • STNE $16.30
  • Resistance Level
  • RNA $69.86
  • STNE $19.45
  • Average True Range (ATR)
  • RNA 0.63
  • STNE 0.64
  • MACD
  • RNA 0.31
  • STNE -0.21
  • Stochastic Oscillator
  • RNA 94.16
  • STNE 47.38

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.

Share on Social Networks: